Share this postExperimental Gene TherapyDetailed analysis of bacterial DNA contamination of RNA gene therapy drugsCopy linkFacebookEmailNotesMoreDetailed analysis of bacterial DNA contamination of RNA gene therapy drugsBret Weinstein and Kevin McKernan discuss SV40Promoter, Kanamycin resistance, and other topics.Robert W. Chandler, MD MBANov 04, 20242Share this postExperimental Gene TherapyDetailed analysis of bacterial DNA contamination of RNA gene therapy drugsCopy linkFacebookEmailNotesMoreShareShots in the Dark: Kevin McKernan on Dark Horse podcastRumble version:VideoDr. McKernan’s substackNepetalactone NewsletterDecentralized MedicineBy Anandamide